By Way of example, in triple destructive breast cancer (TNBC),25 and in hepatocellular carcinoma,26 DNA methylation profiles have served to the identification of unique subgroups with clinical relevance. Epigenetic strategies have also served to the development of prognostic assessments to evaluate the sensitivity of cancer cells to specific drugs.27 https://directivepublications.org/world-journal-of-clinical-cancer-research/